Global Market Study on Fatty Acids Supplements: Marine Oil Segment to Witness Highest Growth by 2020


  • Published On : Dec-2014 |
  • Pages : 84 Pages |
  • Format :

Increasing awareness among consumers about health, diet, and fitness has helped improve lifestyles greatly. Omega-3 is among the best options for consumers looking for a healthy lifestyle. Increasing health awareness and medicinal benefits of fatty acids are major growth drivers for the global fatty acids supplements market. In the past few years, certain health organizations have indicated that omega-3 fatty acids can be useful in the treatment of eye, hair, and heart diseases.

In recent years, infant formula, which is one of the major applications of omega-3, has witnessed significant growth. According to the European Food Safety Authority (EFSA), omega-3 fatty acids can aid cognitive development in infants. Thus, companies such as Nestlé S.A. and Abbott Laboratories have been progressively expanding their product portfolios catering to this segment. For instance, infant formula, such as Similac with OptiGRO and Similac for supplementation, both products of Abbott Laboratories, are available in the market.

The Lower level of consumer awareness acts as a major restraint for the fatty acids supplements market. The situation is adverse in developing parts of the world where literacy rates are low and people have low disposable incomes to spend on dietary supplements. Companies such as Arista Industries, Croda Healthcare, DSM, and Dean Foods are focusing on spreading awareness, especially in high-potential markets in Asia Pacific and Latin America.

North America is the largest market for fatty acids supplements globally, followed by Europe. In 2013, North America accounted for about 35% of the global consumption of omega-3 fatty acids. A growing trend towards consuming beverages with functional ingredients has offered new opportunities for the addition of omega-3, such as EPA and DHA, in beverages. According to the United Soybean Board’s Consumer Attitudes about Nutrition survey,  around 84% of consumers perceived omega-3 as a healthy fatty acid in 2012; and increase from 79% in 2011.

The global fatty acids supplements market is highly consolidated, with the top five companies holding around 75% market share. DSM leads the market, followed by Epax AS and Croda Health Care. 

This report is a detailed study of the global fatty acids supplements market. It offers insights into the current and forecast market scenario. The report examines factors affecting the market movement and changing consumer behavior as well as provides details related to strategic planning of companies for growth and sustenance in the competitive market. Company profiles, included at the end of the report, cover company overview, products and segments, financial performance, and recent developments of various companies.

Key points covered in the report

  • The report provides historic, present, and forecasted market size, analysis, trends, shares, and growth 
  • It segments the market on the basis of source by volume (million tons) and by value (USD million) and on the basis of application by volume (million tons) and by value (USD million) for all geographies
  • The report covers following segmentations
    • On the basis of source:
      • Marine oils
      • Algal oils
      • Others (including flaxseed oils)
    • On the basis of application:
      • Dietary supplements
      • Functional food and beverages
      • Others (including pharmaceuticals and infant formula)
    • On the basis of geography:
      • North America
      • Europe
      • Asia Pacific
      • Rest of the World
  • It profiles some of the leading companies operating in the market
  • The report also includes Porter’s five forces analysis of the market

Increasing health awareness and medicinal benefits of fatty acids are major growth drivers for the global fatty acids market. In the last few years, certain health organizations found omega series fatty acids can aid the treatment of eye, hair, and heart diseases. Increasing consumer base and technology advancement in controlling oxidation (to maintain the quality, taste, and smell of food) in omega-3, omega-6, and omega-9 for improved taste are also expected to drive the demand for fatty acids supplements. Increasing baby boomers population is expected to drive the global fatty acids supplements market. According to the Population Division of the United Nations Department of Economic and Social Affairs (UN-DESA), there were 841 million people aged 60 and above in 2013 compared to 205 million in 1950. The number is projected to reach over 2 billion by 2050.

North America is the largest market for fatty acids supplements globally. In 2013, it contributed to around 35% of the global consumption of omega 3 fatty acids. A major factor contributing to the growth of the omega-3 market in Europe is the increasing level of awareness about omega-3 in the region. In the recent years, consumers have become more conscious of their diet intake. Asia-Pacific is the fastest growing and emerging market for omega-3. Countries such as India and China have high birth rates, which may boost the demand for omega-3 ingredients in infant formula. The birth rate is maximum in India (around 22%), followed by China 12%, in the Asia Pacific region. Omega-3 fats are useful for improving vision and aiding cognitive development in infants. Increasing population and growing urbanization in China has led to the multifold growth of the fatty acids supplements market.

The fatty acids supplements market is bifurcated into the source (marine oils, algal oils, and others) and application (dietary supplements, functional food and beverages, and others). The marine oils segment held the largest share of the overall market in 2013 at 102.7 million tons; and is expected to reach 235.4 million tons by 2020, at a CAGR of 12.7% for the period 2014 – 2020.

Among the application segments, the dietary supplements sector ( a largest sector in 2013) increased by 8.5% CAGR during 2010 – 2013 to reach USD 1,204.5 million in 2013.

Among the regional segments, the North American fatty acids supplements market (largest market in 2013) increased by 9.2% CAGR during 2010 – 2013 to reach USD 688.3 million in 2013. 

The global fatty acids supplements market is highly consolidated, with the top five companies holding around 75% market share. DSM leads the market, followed by Epax AS and Croda Health Care.

global-fatty-acids-supplements-market

global-fatty-acids-supplements-market-2014-2020

Chapter Company Profiles:

  • Epax AS.
  • Arista Industries, Inc.
  • Omega Protein Corporation.
  • Axellus AS.
  • Copeinca AS.
  • Croda Health Care.
  • Koninklijke DSM N.V.

Chapter 1 Preface

1.1 Report Description

     1.1.1 Segments covered in the report

1.2 Research Methodology

Chapter 2 Market Synopsis

Chapter 3 Porter’s Five Forces Model

3.1 Bargaining Power of Suppliers

3.2 Bargaining Power of Buyers

3.3 Threat of New Entrants

3.4 Threat of Substitutes

3.5 Rivalry Among Competitors

Chapter 4 Industry Overview

4.1 Introduction

4.2 Market Drivers

     4.2.1 Healthy lifestyle

     4.2.2 Technology advancements

     4.2.3 Infant formula

     4.2.4 Rising aging population

     4.2.5 Impact analysis of market drivers

4.3 Market Restraints

     4.3.1 Lack of awareness

     4.3.2 Impact analysis of market restraints

4.4 Opportunities

     4.4.1 High birth rate nations

4.5 Challenges

     4.5.1 Decreasing phytoplanktons

Chapter 5 Market Size and Forecast by Source

5.1 Marine Oils

5.2 Algal Oil

5.3 Others (including Flaxseed)

Chapter 6 Market Size and Forecast by Application

6.1 Dietary Supplements

6.2 Functional Food and Beverages

6.3 Others (including Pharmaceuticals and Infant Formula)

Chapter 7 Market Size and Forecast by Geography

7.1 North America

7.2 Europe

7.3 Asia Pacific

Chapter 8 Omega-6 and Omega-9 Fatty Acids, Overview

8.1 Omega-6

     8.1.1 Health benefits of omega-6

     8.1.2 Sources

             8.1.2.1 Sunflower oil

             8.1.2.2 Soybean oil

             8.1.2.3 Palm oil

8.2 Omega-9

     8.2.1 Health benefits of omega-9

     8.2.2 Sources

Chapter 9 Competitive Scenario

9.1 Global Fatty Acids Supplements Market Share, by Company

Chapter 10 Company Profiles

10.1 Epax AS

     10.1.1 Company overview

     10.1.2 Products and services

     10.1.3 Financial performance

     10.1.4 Recent developments

10.2 Arista Industries, Inc.

     10.2.1 Company overview

     10.2.2 Products and services

     10.2.3 Financial performance

     10.2.4 Recent developments

10.3 Omega Protein Corporation 

     10.3.1 Company overview

     10.3.2 Products and services

     10.3.3 Financial performance

     10.3.4 Recent developments

10.4 Axellus AS

     10.4.1 Company overview

     10.4.2 Products and services

     10.4.3 Financial performance

     10.4.4 Recent developments

10.5 Copeinca AS

     10.5.1 Company overview

     10.5.2 Products and services

     10.5.3 Financial performance

     10.5.4 Recent developments

10.6 Croda Health Care

     10.6.1 Company overview

     10.6.2 Products and services

     10.6.3 Financial performance

     10.6.4 Recent developments

10.7 Koninklijke DSM N.V.

     10.7.1 Company overview

     10.7.2 Products and services

     10.7.3 Financial performance

     10.7.4 Recent developments


List of Tables

TABLE 1 Global fatty acids supplements market snapshot, by value, 2014 and 2020

TABLE 2 Global fatty acids supplements market snapshot, by volume, 2014 and 2020

TABLE 3 Impact analysis of market drivers

TABLE 4 Impact analysis of market restraints

TABLE 5 Global fatty acids supplements market, by source, 2010 – 2013 (million tons)

TABLE 6 Global fatty acids supplements market, by source, 2014 – 2020 (million tons)

TABLE 7 Global fatty acids supplements market, by source, 2010 – 2013 (USD million)

TABLE 8 Global fatty acids supplements market, by source, 2014 – 2020 (USD million)

TABLE 9 Marine oils fatty acids supplements market, by geography, 2010 – 2013 (million tons) 

TABLE 10 Marine oils fatty acids supplements market, by geography, 2014 – 2020 (million tons) 

TABLE 11 Marine oils fatty acids supplements market, by geography, 2010 – 2013 (USD million)

TABLE 12 Marine oils fatty acids supplements market, by geography, 2014 – 2020 (USD million)

TABLE 13 Algal oil fatty acids supplements market, by geography, 2010 – 2013 (million tons)

TABLE 14 Algal oil fatty acids supplements market, by geography, 2014 – 2020 (million tons)

TABLE 15 Algal oil fatty acids supplements market, by geography, 2010 – 2013 (USD million)

TABLE 16 Algal oil fatty acids supplements market, by geography, 2014 – 2020 (USD million)

TABLE 17 Others (including flaxseed) fatty acids supplements market, by geography, 2010 – 2013 (million tons)

TABLE 18 Others (including flaxseed) fatty acids supplements market, by geography, 2014 – 2020 (million tons)

TABLE 19 Others (including flaxseed) fatty acids supplements market, by geography, 2010 – 2013 (USD million)

TABLE 20 Others (including flaxseed) fatty acids supplements market, by geography, 2014 – 2020 (USD million)

TABLE 21 Global fatty acids supplements market, by application, 2010 – 2013 (million tons) 

TABLE 22 Global fatty acids supplements market, by application, 2014 – 2020 (million tons)

TABLE 23 Global fatty acids supplements market, by application, 2010 – 2013 (USD million)

TABLE 24 Global fatty acids supplements market, by application, 2014 – 2020 (USD million)

TABLE 25 Dietary supplements market, by geography, 2010 – 2013 (million tons)

TABLE 26 Dietary supplements market, by geography, 2014 – 2020 (million tons)

TABLE 27 Dietary supplements market, by geography, 2010 – 2013 (USD million)

TABLE 28 Dietary supplements market, by geography, 2014 – 2020 (USD million)

TABLE 29 Functional food and beverages market, by geography, 2010 – 2013 (million tons)

TABLE 30 Functional food and beverages market, by geography, 2014 – 2020 (million tons) 

TABLE 31 Functional food and beverages market, by geography, 2010 – 2013 (USD million)

TABLE 32 Functional food and beverages market, by geography, 2014 – 2020 (USD million)

TABLE 33 Others (including pharmaceuticals and infant formula) market, by geography, 2010 – 2013 (million tons)

TABLE 34 Others (including pharmaceuticals and infant formula) market, by geography, 2014 – 2020 (million tons)

TABLE 35 Others (including pharmaceuticals and infant formula) market, by geography, 2010 – 2013 (USD million)

TABLE 36 Others (including pharmaceuticals and infant formula) market, by geography, 2014 – 2020 (USD million)

TABLE 37 Global fatty acids supplements market size, by region, 2010 – 2013 (million tons)

TABLE 38 Global fatty acids supplements market size, by region, 2014 – 2020 (million tons)

TABLE 39 Global fatty acids supplements market size, by region, 2010 – 2013 (USD million)

TABLE 40 Global fatty acids supplements market size, by region, 2014 – 2020 (USD million)

TABLE 41 North America fatty acids supplements market, by source, 2010 – 2013 (million tons) 

TABLE 42 North America fatty acids supplements market, by source, 2014 – 2020 (million tons)

TABLE 43 North America fatty acids supplements market, by source, 2010 – 2013 (USD million)

TABLE 44 North America fatty acids supplements market, by source, 2014 – 2020 (USD million)

TABLE 45 North America fatty acids supplements market, by application, 2010 – 2013 (million tons)

TABLE 46 North America fatty acids supplements market, by application, 2014 – 2020 (million tons)

TABLE 47 North America fatty acids supplements market, by application, 2010 – 2013 (USD million)

TABLE 48 North America fatty acids supplements market, by application, 2014 – 2020 (USD million)

TABLE 49 Europe Fatty acids supplements market, by source, 2010 – 2013 (million tons)

TABLE 50 Europe fatty acids supplements market, by source, 2014 – 2020 (million tons)

TABLE 51 Europe fatty acids supplements market, by source, 2010 – 2013 (USD million)

TABLE 52 Europe fatty acids supplements market, by source, 2014 – 2020 (USD million)

TABLE 53 Europe fatty acids supplements market, by application, 2010 – 2013 (million tons)

TABLE 54 Europe fatty acids supplements market, by application, 2014 – 2020 (million tons)

TABLE 55 Europe fatty acids supplements market, by application, 2010 – 2013 (USD million)

TABLE 56 Europe fatty acids supplements market, by application, 2014 – 2020 (USD million)

TABLE 57 Asia Pacific fatty acids supplements market, by source, 2010 – 2013 (million tons)

TABLE 58 Asia Pacific fatty acids supplements market, by source, 2014 – 2020 (million tons)

TABLE 59 Asia Pacific fatty acids supplements market, by source, 2010 – 2013 (USD million) 

TABLE 60 Asia Pacific fatty acids supplements market, by source, 2014 – 2020 (USD million)

TABLE 61 Asia Pacific fatty acids supplements market, by application, 2010 – 2013 (million tons)

TABLE 62 Asia Pacific fatty acids supplements market, by application, 2014 – 2020 (million tons)

TABLE 63 Asia Pacific fatty acids supplements market, by application, 2010 – 2013 (USD million)

TABLE 64 Asia Pacific fatty acids supplements market, by application, 2014 – 2020 (USD million)

TABLE 65 Product line of Epax AS

TABLE 66 Arista Industries, Inc. product line

TABLE 67 Products and segments of Omega Protein Corporation

TABLE 68 Product line of Axellus AS 

TABLE 69 Product line of Croda Health Care

TABLE 70 Products and product classifications of DSM


List of Figures 

FIG. 1 Global fatty acids supplements market, 2010 – 2020 (USD million)

FIG. 2 Fatty acids supplement: Porter’s five forces analysis

FIG. 3 Global birth rate, 2012

FIG. 4 Global sunflower oil production, 2008 – 2012 (million metric tons)

FIG. 5 Global soybean oil production, 2008 – 2012 (million metric tons)

FIG. 6 Global palm oil production, 2008 – 2012 (million metric tons)

FIG. 7 Global fatty acids supplements market share, by company, 2013

FIG. 8 Omega Protein Corporation’s net sales and net profit, 2011 – 2013 (USD million)

FIG. 9 Orkla Home & Personal’s net sales and net profit, 2011 – 2013 (USD million)

FIG. 10 Croda International Plc’s net sales and net profit, 2011 – 2013 (USD million)

FIG. 11 Koninklijke DSM N.V.’s net sales and profit, 2011 – 2013 (USD million)

Back To Top